|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 35/02 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3245231 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16702306.8 |
| Europos patento paraiškos padavimo data | 2016-01-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-11-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/013808 |
| Data | 2016-01-18 |
| (87) | Numeris | WO 2016/115559 |
| Data | 2016-07-21 |
| (30) | Numeris | Data | Šalis |
| 201562104664 P | 2015-01-16 | US |
| (72) |
CHEN, Yan, US
SHAMAH, Steven M., US
PAZMANY, Csaba, US
DUTTA-SIMMONS, Jui, US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1 |
| ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1 |